Three-dimensional amide proton transfer-weighted imaging for differentiating between glioblastoma, idh-wildtype and primary central nervous system lymphoma

HIGHLIGHTS

• who: Shigeo Ohba and collaborators from the Department of Neurosurgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan have published the article: Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma, in the Journal: Cancers 2023, 952 of /2023/
• what: The authors evaluated whether a specific kind of chemical exchange saturation transfer imaging i.e. amide proton transfer-weighted (APTw) imaging was useful to distinguish from A total of 14 and 27 cases were evaluated. In this report, the authors aimed to evaluate whether . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.